Certain Sglt2 Inhibitors Glp1 Ras For T2dm Also Cut Cv Risk | Latest News RSS feed

Certain Sglt2 Inhibitors Glp1 Ras For T2dm Also Cut Cv Risk - Latest News


Certain SGLT2 inhibitors, GLP-1 RAs for T2DM also cut CV risk

(HealthDay)—Certain sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) demonstrate significant cardiovascular (CV) benefit and should be used ... read more

Glycemic Control, Weight Changes, Hypoglycemia Risk: Diabetes Drugs Compared

The smallest reduction in HbA1c was seen in patients taking DPP-4 inhibitors (0.58%–0.72%). The study authors also reported that reductions ... They added, “Hypoglycemia risk for DPP-4 inhibitors, ... read more

Certain SGLT2 Inhibitors, GLP-1 RAs for T2DM Also Cut CV Risk

(HealthDay News) -- Certain sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) demonstrate significant cardiovascular (CV) benefit and should ... read more

Looking for another news?


Women with CVD have worse self-reported outcomes

(HealthDay)—Compared with men, women with atherosclerotic cardiovascular disease (ASCVD) are more likely to report poorer patient experience, lower health-related quality of life, and poorer ... read more


Certain SGLT2 Inhibitors, GLP-1 RAs for T2DM Also Cut CV Risk

Report provides guidance on reducing CV risk in patients with T2DM and atherosclerotic CV disease (HealthDay News) — Certain sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide ... read more

Certain SGLT2 Inhibitors, GLP-1 RAs for T2DM Also Cut CV Risk

Report provides guidance on reducing CV risk in patients with T2DM and atherosclerotic CV disease (HealthDay News) — Certain sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us